Interest areas: I am trained as a pharmacologist in the areas of neuropharmacology, cancer, gastrointestinal, cardiovascular, pulmonary, antimicrobial, and metabolic disorders. As a faculty and an independent researcher, I want to dedicate my efforts to teaching and research. My interest lies in developing more effective therapeutic regimens to enhance treatment efficacy and minimize adverse effects. My lab will be rooted in the following areas:
- Therapeutic target identification and validation
- Understanding the molecular mechanisms underlying disease progression and resistance to current therapies
- Drug design and discovery (Structure-based, Ligand-based drug design, AI-driven drug discovery)
- Ethnopharmacology
- Evaluating molecules and drugs for their efficacy, pharmacokinetics, mechanistic insights, and toxicological screening using both in vitro and in vivo preclinical disease models
- Develop novel drug delivery systems and formulation strategies
- Bioavailability and Bioequivalence studies
Awards:
- Received fellowships (Junior Research Fellow and Senior Research Fellow) during Ph.D. from Government of India, Ministry of Human Resource and Development (MHRD) and IIT(BHU).
- Institutional travel grant from IIT(BHU) in 2018, to present Ph.D. research work at Advanced Centre for Treatment, Research & Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, India.
- Received fellowship during M.Pharm from Government of India, All India Council for Technical Education (AICTE).
Industrial Collaboration : 02
Number of Publications: 15
Recent Publications:
- Naz Z, Fareed M, Snigdha N T, Zafar A, Alsaidan O A, Aslam M, Mangu K, Neogi K, Ahmad S, Rizwanullah Md. Harnessing the Power of D-Alpha-Tocopheryl Polyethylene Glycol Succinate-Based Nanoparticles for Targeted Breast Cancer Therapy. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology. 2025, 17(6): e70040. DOI: https://doi.org/10.1002/wnan.70040.
- Neogi K, Murumkar PR, Sharma P, Yadav P, Tewari M, Karunagaran D, Nayak PK, Yadav MR. Design, synthesis and evaluation of 4,7-disubstituted 8-methoxyquinazoline derivatives as potential cytotoxic agents targeting β-catenin/TCF4 signaling pathway. Translational Oncology. 2022, 19:101395. DOI: https://doi.org/10.1016/j.tranon.2022.101395
- Neogi K, Tewari M, Singh AK, Sharma K, Tej GNVC, Verma SS, Gupta SC, Nayak PK. Transcription factor 4 expression and correlation with tumor progression in gallbladder cancer. Journal of Cancer Research and Therapeutics. 2022, 18:668-676. DOI: 10.4103/jcrt.jcrt_1381_21
- Alla SK, Gangwar A, Shaw S, Viswanadh MK, Neogi K, Muthu MS, Gupta N, Meena SS, Kollu P, Mandal RK, Prasad NK. Physical and in-vitro evaluation of pure and substituted MxCe1-xO2 (M= Co, Fe or Ti and x = 0.05) magnetic nanoparticles. Ceramics International. 2021, 47(7, Part A):8812-8819. DOI: https://doi.org/10.1016/j.ceramint.2020.12.001
- Viswanadh MK, Vikas, Jha A, Reddy Adena SK, Mehata AK, Priya V, Neogi K, Poddar S, Mahto SK, Muthu MS. Formulation and in vivo efficacy study of cetuximab decorated targeted bioadhesive nanomedicine for non-small-cell lung cancer therapy. Nanomedicine. 2020, 15(24):2345-2367. DOI: https://doi.org/10.2217/nnm-2020-0167
- Gangwar A, Varghese SS, Meena SS, Viswanadh MK, Neogi K, Muthu MS, Prasad NK. Physical and in vitro evaluation of ultra-fine cohenite particles for the prospective magnetic hyperthermia application. Journal of Materials Science: Materials in Electronics. 2020, 31:10772-10782. DOI: https://doi.org/10.1007/s10854-020-03628-9
- Gangwar A, Varghese SS, Sharma A, Meena SS, Prajapat CL, Viswanadh MK, Neogi K, Muthu MS, Prasad NK. Physical and in-vitro evaluation of ϵ-Fe3N@Fe3O4 nanoparticles for bioapplications. Ceramics International 2020, 46(8, Part A):10952-10962. DOI: https://doi.org/10.1016/j.ceramint.2020.01.110
- Gangwar A, Kumar S, Meena SS, Sharma A, Viswanadh MK, Neogi K, Muthu MS, Prasad NK. Structural and in-vitro assessment of ZnxFe3− xC (0≤ x≤ 1) nanoparticles as magnetic biomaterials. Applied Surface Science. 2020, 509:144891. DOI: https://doi.org/10.1016/j.apsusc.2019.144891
- Tej GNVC, Neogi K, Nayak PK. Caffeine-enhanced anti-tumor activity of anti-PD1 monoclonal antibody. International immunopharmacology. 2019, 77:106002. DOI: https://doi.org/10.1016/j.intimp.2019.106002
- Singh AK, Mishra H, Firdaus Z, Yadav S, Aditi P, Nandy N, Sharma K, Bose P, Pandey AK, Chauhan BS, Neogi K, Vikram K, Srivastava A, Kar AG, Prakash P. MoS2-modified curcumin nanostructures: the novel theranostic hybrid having potent antibacterial and antibiofilm activities against multidrug-resistant hypervirulent klebsiella pneumoniae. Chemical research in toxicology. 2019, 32(8):1599-1618. DOI: https://doi.org/10.1021/acs.chemrestox.9b00135
- Tej GNVC, Neogi K, Verma SS, Gupta SC, Nayak PK. Caffeine-enhanced anti-tumor immune response through decreased expression of PD1 on infiltrated cytotoxic T lymphocytes. European journal of pharmacology. 2019, 859:172538. DOI: https://doi.org/10.1016/j.ejphar.2019.172538
- Singh AK, Yadav S, Chauhan BS, Nandy N, Singh R, Neogi K, Roy JK, Srikrishna S, Singh RK, Prakash P. Classification of Clinical Isolates of Klebsiella pneumoniae based on their in vitro Biofilm forming capabilities and Elucidation of the Biofilm Matrix Chemistry with special reference to the Protein content. Frontiers in microbiology. 2019, DOI: 10:669. https://doi.org/10.3389/fmicb.2019.00669
- Shivavedi N, Tej GNVC, Neogi K, Nayak PK. Ascorbic acid therapy: a potential strategy against comorbid depression-like behavior in streptozotocin-nicotinamide-induced diabetic rats. Biomedicine & Pharmacotherapy. 2019, 109:351-359. DOI: https://doi.org/10.1016/j.biopha.2018.10.070
- Singh AK, Yadav S, Sharma K, Firdaus Z, Aditi P, Neogi K, Bansal M, Gupta MK, Shanker A, Singh RK, Prakash P. Quantum curcumin mediated inhibition of gingipains and mixed-biofilm of Porphyromonas gingivalis causing chronic periodontitis. RSC advances. 2018, 8(70):40426-40445. DOI: https://doi.org/10.1039/C8RA08435A
Professional memberships:
- Member of International Society for Extracellular Vesicles
- Member of The New York Academy of Sciences
- Registered Pharmacist at Delhi State Pharmacy Council, India
Other achievements/ Trainings:
- Poster presentation entitled “Design, synthesis and evaluation of 4,7-disubstituted 8-methoxyquinazoline derivatives as potential anti-cancer agents targeting β-catenin/TCF4 signaling pathway’ in 18th Annual Cancer Symposium organized by Beth Israel Deaconess Medical Center (BIDMC), Harvard Medical School, Boston, USA held on 21 Nov 2025.
- Qualified IIT (BHU) Ph.D. entrance exam in 2016 and secured 1st position in Pharmacology specialization
- Qualified Jamia Hamdard M.Pharm admission entrance exam in 2013
- Qualified National Institute of Pharmaceutical Education and Research Joint Entrance Examination (NIPER JEE) in 2013 for M.Pharm admission
- Qualified Graduate Pharmacy Aptitude Test (GPAT) entrance exam in 2013
- Secured highest marks in XII standard in chemistry & biology
- Awarded a certificate of special achievement for outstanding academic performance for securing the highest marks in science (93%) in class X standard
- Journal Reviewing Editor – Springer Nature
- Journal Reviewer (Voulnteer)- Scientific Reports, Frontiers in Oncology, The International Journal of Polymeric Materials and Polymeric Biomaterials, Indian Journal of Pharmaceutical Sciences; Journal of Herbal Medicine; Scientific Journal of Depression & Anxiety; The Journal of Nanobiotechnology; BMC Microbiology; Frontiers in Pharmacology; Circulation Research; Arteriosclerosis, Thrombosis, and Vascular Biology; American Journal of Respiratory and Critical Care Medicine; Circulation; Tissue and Cell; Scientifica
Official email ID: kaushik.neogi@nmims.edu
Official Phone No.: 02563- 295545
